YSP Aspirin Side Effects

Generic Name: aspirin

Note: This page contains side effects data for the generic drug aspirin. It is possible that some of the dosage forms included below may not apply to the brand name YSP Aspirin.

It is possible that some side effects of YSP Aspirin may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

For the Consumer

Applies to aspirin: oral capsules, oral gum, oral tablets, rectal suppositories

Side effects include:

Minor upper GI symptoms (dyspepsia).

For Healthcare Professionals

Applies to aspirin: compounding powder, oral delayed release capsule, oral delayed release tablet, oral gum, oral powder for reconstitution, oral tablet, oral tablet chewable, oral tablet disintegrating, oral tablet dispersible, oral tablet extended release, rectal suppository

Gastrointestinal

Endoscopically identifiable gastric mucosal lesions occur in most patients who receive a single dose of aspirin (the active ingredient contained in YSP Aspirin) Clinically evident gastrointestinal bleeding has been reported in as many as 3% of treated elderly patients. Anorectal ulceration and rectal stenosis have been reported in patients who abuse aspirin-containing rectal suppositories. One case-controlled study has suggested that an association between aspirin (and other NSAID) consumption and appendicitis may exist.

The risk of developing dyspeptic events (i.e., epigastric pain, heartburn, nausea, ulcers) is low in rheumatic patients with no prior gastrointestinal symptoms who receive low-dose (less than 650 mg/day) aspirin therapy.[Ref]

Gastrointestinal side effects have included epigastric distress (in as many as 83% of patients treated with regular aspirin), abdominal discomfort or pain, endoscopically identifiable gastric mucosal lesions, nausea, and vomiting. More serious gastrointestinal effects include hemorrhage, peptic ulcers, perforation, small bowel enteropathy, and esophageal ulcerations.[Ref]

Renal

The mechanism of an aspirin-induced decrease in renal function may be related to inhibition of renal prostaglandin synthesis with consequent decreases in renal blood flow. Vasodilating renal prostaglandins may be particularly important in patients who exhibit arterial underfilling (i.e. heart failure, cirrhosis). The administration of high doses of NSAIDs to such patients has produced acute renal failure in rare instances.[Ref]

Renal side effects have included reduction in glomerular filtration rate (particularly in patients who are sodium restricted or who exhibit diminished effective arterial blood volume, such as patients with advanced heart failure or cirrhosis), interstitial nephritis, papillary necrosis, elevations in serum creatinine, elevations in blood urea nitrogen, proteinuria, hematuria, and renal failure.[Ref]

Hematologic

Hematologic side effects have included increased blood fibrinolytic activity. In addition, hypoprothrombinemia, thrombocytopenia, thrombocyturia, megaloblastic anemia, and pancytopenia have been reported rarely. Aplastic anemia and eosinophilia have also been reported.[Ref]

Hypersensitivity

The mechanism of aspirin-induced hypersensitivity may be related to an up-regulation of the 5-lipoxygenase pathway of arachidonic acid metabolism with a resulting increase in the products of 5-lipoxygenase (such as leukotrienes).[Ref]

Hypersensitivity side effects have included bronchospasm, rhinitis, conjunctivitis, urticaria, angioedema, and anaphylaxis. Approximately 10% to 30% of asthmatics are aspirin-sensitive (with the clinical triad of aspirin sensitivity, bronchial asthma, and nasal polyps).[Ref]

Dermatologic

Dermatologic side effects have included Stevens-Johnson syndrome and a lichenoid eruption. In addition, isolated cases of unilateral aquagenic wrinkling of the palms and papuloerythroderma have been associated with aspirin (the active ingredient contained in YSP Aspirin) therapy.[Ref]

Hepatic

Hepatic side effects have included hepatotoxicity and cholestatic hepatitis.[Ref]

Oncologic

Oncologic side effects have included reports of pancreatic cancer. Several epidemiologic studies have suggested that chronic aspirin (the active ingredient contained in YSP Aspirin) use may decrease the risk of large bowel neoplasms. However, other studies have not found such a beneficial effect.[Ref]

Metabolic

Metabolic side effects have included dehydration and hyperkalemia. Respiratory alkalosis and metabolic acidosis, particularly during salicylate toxicity, have been reported. A case of hypoglycemia has been reported in a patient on hemodialysis. Salicylates have also been reported to displace triiodothyronine (T3) and thyroxine (T4) from protein binding sites. The initial effect is an increase in serum free T4 concentrations.[Ref]

Cardiovascular

A 29-year-old female with a history of migraine developed chest pain, tachycardia and orthopnea following aspirin (the active ingredient contained in YSP Aspirin) consumption at doses of 1500 mg per day for several days. After discontinuation of aspirin therapy, the patient's symptoms promptly resolved. The patient consented to a pharmacological challenge test which once again triggered the symptoms.[Ref]

Cardiovascular side effects have included salicylate-induced variant angina, ventricular ectopy, conduction abnormalities, and hypotension, particularly during salicylate toxicity. In addition, at least one case of fluid retention simulating acute congestive heart failure has been reported during aspirin therapy. Antiplatelet therapy has also been associated with acute deterioration of intracerebral hemorrhage.[Ref]

Nervous system

Central nervous system side effects have included agitation, cerebral edema, coma, confusion, dizziness, headache, cranial hemorrhage, lethargy and seizures. Tinnitus and subjective hearing loss (or both) may occur. Some investigators have reported that modest doses may result in decreased frequency selectivity and may therefore impair hearing performance, particularly in the setting of background noise.[Ref]

Some investigators have suggested that tinnitus may be a less reliable indicator of salicylate toxicity than previously believed. Patients with high frequency hearing loss may have difficulty perceiving tinnitus. In a study of rheumatoid arthritis patients, those with tinnitus had no greater salicylate levels than those without tinnitus. Elderly patients may be less likely to perceive tinnitus than younger patients.[Ref]

Other

Reye's syndrome typically involves vomiting, neurologic dysfunction, and hepatic dysfunction during or shortly after an acute viral infection.[Ref]

Other side effects have included Reye's syndrome with aspirin use in children with an acute viral illness. Reye's syndrome has also been reported even more rarely in adults.[Ref]

Musculoskeletal

Musculoskeletal side effects have included rhabdomyolysis.[Ref]

Respiratory

Respiratory side effects have included hyperpnea, pulmonary edema, and tachypnea.[Ref]

Aspirin desensitization has been used to decrease disease activity and reduce the need for systemic corticosteroids in patients with aspirin-exacerbated respiratory disease.[Ref]

Endocrine

Endocrine side effects have included hypoglycemia (which has been reported in children) and hyperglycemia.[Ref]

Ocular

Ocular side effects have included cases of localized periorbital edema.[Ref]

References

1. Graham DY, Smith JL "Aspirin and the stomach." Ann Intern Med 104 (1986): 390-8

2. "Product Information. Bayer aspirin (aspirin)." Bayer, West Haven, CT.

3. Greenberg PD, Cello JP, Rockey DC "Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease." Am J Med 100 (1996): 598-604

4. Sabesin SM, Boyce HW Jr, King CE, Mann JA, Ruoff G, Wall E "Comparative evaluation of gastrointestinal intolerance produced by plain and tri-buffered aspirin tablets." Am J Gastroenterol 83 (1988): 1220-5

5. Vallurupalli NG, Goldhaber SZ "Gastrointestinal complications of dual antiplatelet therapy." Circulation 113 (2006): e655-8

6. Joseph M "Adverse drug reactions as cause of admission to hospital: only part of the picture was reported for aspirin." BMJ 329 (2004): 459; author reply 460

7. Prichard PJ, Kitchingman GK, Walt RP, Daneshmend TK, Hawkey CJ "Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin." BMJ 298 (1989): 493-6

8. D'Haens G, Breysem Y, Rutgeerts P, van Besien B, Geboes K, Ponette E, Vantrappen G "Proctitis and rectal stenosis induced by nonsteroidal antiinflammatory suppositories." J Clin Gastroenterol 17 (1993): 207-12

9. Thomas J, Straus WL, Bloom BS "Over-the-counter nonsteroidal anti-inflammatory drugs and risk of gastrointestinal symptoms." Am J Gastroenterol 97 (2002): 2215-9

10. Wilcox CM, Shalek KA, Cotsonis G "Striking prevalence of over-the-counter nonsteroidal anti- inflammatory drug use in patients with upper gastrointestinal hemorrhage." Arch Intern Med 154 (1994): 42-6

11. Ferraris VA, Ferraris SP "Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting - update." Ann Thorac Surg 59 (1995): 1036-7

12. Schaffer D, Florin T, Eagle C, et al. "Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review." Med J Aust 185 (2006): 501-6

13. Thirlby RC "More problems with aspirin: it may cause appendicitis." Gastroenterology 104 (1993): 1571-3

14. Lanas A, Serrano P, Bajador E, Esteva F, Benito R, Sainz R "Evidence of aspirin use in both upper and lower gastrointestinal perforation." Gastroenterology 112 (1997): 683-9

15. Benito-Garcia E, Michaud K, Wolfe F "The effect of low-dose aspirin on the decreased risk of development of dyspepsia and gastrointestinal ulcers associated to cyclooxygenase-2 selective inhibitors." J Rheumatol 34 (2007): 1765-9

16. Roderick PJ, Wilkes HC, Meade TW "The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials." Br J Clin Pharmacol 35 (1993): 219-26

17. Weil J, Colinjones D, Langman M, Lawson D, Logan R, Murphy M, Rawlins M, Vessey M, Wainwright P "Prophylactic aspirin and risk of peptic ulcer bleeding." BMJ 310 (1995): 827-30

18. Naschitz JE, Yeshurun D, Odeh M, Bassan H, Rosner I, Stermer E, Levy N "Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease." Am J Gastroenterol 85 (1990): 408-11

19. Dickinson JP, Prentice CRM "Aspirin: benefit and risk in thromboprophylaxis." Qjm Mon J Assoc Physician 91 (1998): 523-38

20. Stalnikowiczdarvasi R "Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events: a critical analysis." J Clin Gastroenterol 21 (1995): 13-6

21. Mehta S, Dasarathy S, Tandon RK, Mathur M, Malaviya AN "A prospective randomized study of the injurious effects of aspirin and naproxen on the gastroduodenal mucosa in patients with rheumatoid arthritis." Am J Gastroenterol 87 (1992): 996-1000

22. Bergmann JF, Chassany O, Geneve J, Abiteboul M, Caulin C, Segrestaa JM "Endoscopic evaluation of the effect of ketoprofen, ibuprofen and aspirin on the gastroduodenal mucosa." Eur J Clin Pharmacol 42 (1992): 685-8

23. Marks RD "Aspirin use and fecal occult blood testing." Am J Med 100 (1996): 596-7

24. Neafsey PJ "Low-dose aspirin interactions." Home Healthc Nurse 22 (2004): 54-5

25. Savon JJ, Allen ML, Dimarino AJ, Hermann GA, Krum RP "Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration." Am J Gastroenterol 90 (1995): 581-5

26. Tarone RE, Lipworth L, McLaughlin JK "Serious gastrointestinal events from low dose analgesic use." J Rheumatol 31 (2004): 1008-9; author reply 1010-1

27. Levy M, Miller DR, Kaufman DW, Siskind V, Schwingl P, Rosenberg L, Strom B, Shapiro S "Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics." Arch Intern Med 148 (1988): 281-5

28. Silagy CA, McNeil JJ, Donnan GA, Tonkin AM, Worsam B, Campion K "Adverse effects of low-dose aspirin in a healthy elderly population." Clin Pharmacol Ther 54 (1993): 84-9

29. Campo A "Acetaminophen, aspirin, and renal failure." N Engl J Med 346 (2002): 1588-9; discussion 1588-9

30. Carmichael J, Shankel SW "Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function." Am J Med 78 (1985): 992-1000

31. Wen SF, Parthasarathy R, Iliopoulos O, Oberley TD "Acute renal failure following binge drinking and nonsteroidal antiinflammatory drugs." Am J Kidney Dis 20 (1992): 281-5

32. Riegger GA, Kahles HW, Elsner D, Kromer EP, Kochsiek K "Effects of acetylsalicylic acid on renal function in patients with chronic heart failure." Am J Med 90 (1991): 571-5

33. Kimberly RP, Plotz PH "Aspirin-induced depression of renal function." N Engl J Med 296 (1977): 418-24

34. Segal R, Lubart E, Leibovitz A, et al. "Early and late effects of low-dose aspirin on renal function in elderly patients." Am J Med 115 (2003): 462-6

35. Muther RS, Potter DM, Bennett WM "Aspirin-induced depression of glomerular filtration rate in normal humans: role of sodium balance." Ann Intern Med 94 (1981): 317-21

36. Whelton A "Renal effects of over-the-counter analgesics." J Clin Pharmacol 35 (1995): 454-63

37. Maher JF "Analgesic nephropathy. Observations, interpretations, and perspective on the low incidence in America." Am J Med 76 (1984): 345-8

38. Barrow MV, Quick DT, Cunningham RW "Salicylate hypoprothrombinemia in rheumatoid arthritis with liver disease. Report of two cases." Arch Intern Med 120 (1967): 620-4

39. Garg SK, Sarker CR "Aspirin-induced thrombocytopenia on an immune basis." Am J Med Sci 267 (1974): 129-32

40. Cheng TI, Cheng TJ, Chiang SC "Association of aspirin with eosinophilia in peripheral blood (December)." Ann Pharmacother 38 (2004): 2172-3

41. Petty GW, Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO "Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention: a population study." Ann Intern Med 130 (1999): 14-22

42. Eldar M, Aderka D, Shoenfeld Y, Livni E, Pinkhas J "Aspirin-induced aplastic anaemia." S Afr Med J 55 (1979): 318

43. Williams JO, Mengel CE, Sullivan LW, Haq AS "Megaloblastic anemia associated with chronic ingestion of an analgesic." N Engl J Med 280 (1969): 312-3

44. Moroz LA "Increased blood fibrinolytic activity after aspirin ingestion." N Engl J Med 296 (1977): 525-9

45. Hirsh J, Dalen JE, Fuster V, Harker LB, Patrono C, Roth G "Aspirin and other platelet-active drugs: the relationship among dose, effectiveness, and side effects." Chest 108 Suppl (1995): s247-57

46. Fausa O "Salicylate-induced hypoprothrombinemia: a report of four cases." Acta Med Scand 188 (1970): 403-8

47. Sutor AH "Thrombocyturia after aspirin." N Engl J Med 288 (1973): 794-5

48. Wijnja L, Snijder JA, Nieweg HO "Acetylsalicylic acid as a cause of pancytopenia from bone-marrow damage." Lancet 2 (1966): 768-70

49. The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators "A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina." N Engl J Med 338 (1998): 1498-505

50. Toyoda K, Okada Y, Minematsu K, et al. "Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage." Neurology 65 (2005): 1000-4

51. Nasser SMS, Lee TH "Aspirin-induced early and late asthmatic responses." Clin Exp Allergy 25 (1995): 1-3

52. Lee TH "Mechanism of bronchospasm in aspirin-sensitive asthma." Am Rev Respir Dis 148 (1993): 1442-3

53. Chan TY "Severe asthma attacks precipitated by NSAIDs." Ann Pharmacother 29 (1995): 199

54. Kowalski ML, Sliwinska-Kowalska M, Igarashi Y, White MV, Wojciechowska B, Brayton P, Kaulbach H, Rozniecki J, Kaliner MA "Nasal secretions in response to acetylsalicylic acid." J Allergy Clin Immunol 91 (1993): 580-98

55. Higashi N, Taniguchi M, Mita H, Higashi A, Akiyama K "Aspirin-induced urticaria and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma." J Allergy Clin Immunol 110 (2002): 666-7

56. Katz Y, Goldberg N, Kivity S "Localized periorbital edema induced by aspirin." Allergy 48 (1993): 366-9

57. Israel E, Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Shapiro J, Cohn J, Rubin P, Drazen JM "The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin." Am Rev Respir Dis 148 (1993): 1447-51

58. Hempel SL, Elliott DE "Chest pain in an aspirin-sensitive asthmatic patient: eosinophilic esophagitis causing esophageal dysmotility." Chest 110 (1996): 1117-20

59. Mastalerz L, Sanak M, Gawlewicz A, Gielicz A, Faber J, Szczeklik A "Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria." J Allergy Clin Immunol 118 (2006): 957-8

60. Analysis of Reports to the Spontaneous Reporting System of the Gruppo Italiano Studi Epidemiiologici in Dermatologia. "Cutaneous reactions to analgesic-antipyretics and nonsteroidal anti- inflammatory drugs." Dermatology 186 (1993): 164-9

61. Khuu PT, Duncan KO, Kwan A, Hoyme HE, Bruckner AL "Unilateral aquagenic wrinkling of the palms associated with aspirin intake." Arch Dermatol 142 (2006): 1661-2

62. Asero R "Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria." J Allergy Clin Immunol 111 (2003): 1095-8

63. Sugita K, Koga C, Yoshiki R, Izu K, Tokura Y "Papuloerythroderma caused by aspirin." Arch Dermatol 142 (2006): 792-3

64. Bharija SC, Belhaj MS "Acetylsalicylic acid may induce a lichenoid eruption." Dermatologica 177 (1988): 19

65. Wolfe JD, Metzger AL, Goldstein RC "Aspirin hepatitis." Ann Intern Med 80 (1974): 74-6

66. Seaman WE, Ishak KG, Plotz PH "Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus." Ann Intern Med 80 (1974): 1-8

67. Sbarbaro JA, Bennett RM "Aspirin hepatotoxicity and disseminated intravascular coagulation." Ann Intern Med 86 (1977): 183-5

68. Pearson RE, Salter FJ "Drug interaction? Orphenadrine with propoxyphene." N Engl J Med 282 (1970): 1215

69. Juurlink DN "Drug-induced hepatotoxicity." N Engl J Med 349 (2003): 1974-6; author reply 1974-6

70. Everson RB, Schreinemachers DM "Use of aspirin and cancer risk in a prospective cohort study (Meeting abstract)." Proc Annu Meet Am Assoc Cancer Res 34 (1993): a1580

71. Greenberg ER, Baron JA "Prospects for preventing colorectal cancer death." J Natl Cancer Inst 85 (1993): 1182-4

72. Smigel K "Aspirin's next conquest: does it prevent colon cancer?" J Natl Cancer Inst 86 (1994): 166-8

73. Greenberg ER, Baron JA, Freeman DH Jr, Mandel JS, Haile R "Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group." J Natl Cancer Inst 85 (1993): 912-6

74. Spurgeon D "Pancreatic cancer is associated with long term use of aspirin." BMJ 328 (2004): 70

75. Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH "Low-dose aspirin and incidence of colorectal tumors in a randomized trial." J Natl Cancer Inst 85 (1993): 1220-4

76. Al-Abbasi AH "Salicylate-induced variant angina." Am Heart J 106 (1983): 1450

77. Surks MI, Sievert R "Drugs and thyroid function." N Engl J Med 333 (1995): 1688-94

78. Berg KJ "Acute acetylsalicylic acid poisoning: treatment with forced alkaline diuresis and diuretics." Eur J Clin Pharmacol 12 (1977): 111-6

79. Mukerji V, Alpert MA, Flaker GC, Beach CL, Weber RD "Cardiac conduction abnormalities and atrial arrhythmias associated with salicylate toxicity." Pharmacotherapy 6 (1986): 41-3

80. David DS, Steere AC Jr, Pi-Sunyer XF, Sakai S, Clark SB "Aspirin-induced hypoglycaemia in a patient on haemodialysis." Lancet 2 (1971): 1092-3

81. Boissel JP "Individualizing aspirin therapy for prevention of cardiovascular events." JAMA 280 (1998): 1949-50

82. Halla JT, Hardin JG "Salicylate ototoxicity in patients with rheumatoid arthritis: a controlled study." Ann Rheum Dis 47 (1988): 134-7

83. Boettcher FA, Salvi RJ "Salicylate ototoxicity: review and synthesis." Am J Otolaryngol 12 (1991): 33-47

84. Colwell JA "Aspirin and risk of hemorrhagic stroke." JAMA 282 (1999): 731-2

85. He J, Whelton PK, Vu B, Klag MJ "Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials." JAMA 280 (1998): 1930-35

86. Carlyon RP, Butt M "Effects of aspirin on human auditory filters." Hear Res 66 (1993): 233-44

87. McGovern MC, Glasgow JFT, Stewart MC "Lesson of the week - Reye's syndrome and aspirin: lest we forget." Br Med J 322 (2001): 1591-2

88. Epidemiology Office, Divisiion of Viral and Rickettsial Diseasses, Center for Infectious Diseases, Centers for Disease Control. "Leads from the MMWR. Reye syndrome surveillance--United States, 1987 and 1988." JAMA 261 (1989): 3520,

89. Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB "Reye's syndrome in the United States from 1981 through 1997." N Engl J Med 340 (1999): 1377-82

90. Volkman JA, Pontikes PJ "Leukotriene modifiers to prevent aspirin-provoked respiratory reactions in asthmatics." Ann Pharmacother 36 (2002): 1457-61

91. Berges-Gimeno MP, Simon RA, Stevenson DD "Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease." J Allergy Clin Immunol 111 (2003): 180-6

92. Szczeklik A, Stevenson DD "Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management." J Allergy Clin Immunol 111 (2003): 913-21

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web3)